
Osteotec entered into a new partnership with SI-BONE to exclusively distribute the iFuse Implant System in the UK and Ireland.
The iFuse Implant System is designed to provide immediate SI joint stabilization and allow long-term fusion. To date, more than 55,000 minimally invasive surgical SI joint fusions have been performed with the iFuse Implant System by more than 2,400 surgeons worldwide.
“We are pleased to be expanding our product offering to include the iFuse Implant System, and to be working with the UK’s top spine surgeons to give them more options, expand our treatment offering and deliver better patient outcomes,” said Dean Stockwell, Osteotec Sales & Marketing Director.
“We are excited about working with Osteotec to expand our footprint in the UK and Ireland,” said Neville Lorimer, SI-BONE Vice President, International.
Source: Osteotec
Osteotec entered into a new partnership with SI-BONE to exclusively distribute the iFuse Implant System in the UK and Ireland.
The iFuse Implant System is designed to provide immediate SI joint stabilization and allow long-term fusion. To date, more than 55,000 minimally invasive surgical SI joint fusions have been performed with the iFuse...
Osteotec entered into a new partnership with SI-BONE to exclusively distribute the iFuse Implant System in the UK and Ireland.
The iFuse Implant System is designed to provide immediate SI joint stabilization and allow long-term fusion. To date, more than 55,000 minimally invasive surgical SI joint fusions have been performed with the iFuse Implant System by more than 2,400 surgeons worldwide.
“We are pleased to be expanding our product offering to include the iFuse Implant System, and to be working with the UK’s top spine surgeons to give them more options, expand our treatment offering and deliver better patient outcomes,” said Dean Stockwell, Osteotec Sales & Marketing Director.
“We are excited about working with Osteotec to expand our footprint in the UK and Ireland,” said Neville Lorimer, SI-BONE Vice President, International.
Source: Osteotec
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





